home All News open_in_new Full Article

Ozempic maker Novo Nordisk to cut 9,000 jobs amid increased competition

Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly Business live – latest newsThe maker of the weight-loss and diabetes drugs Ozempic and Wegovy is to cut 9,000 jobs as it issued a profit warning amid increased competition from the US rival Eli Lilly.Novo Nordisk’s decision to cut 11% of its global workforce comes as sales of its diabetes drugs including Ozempic have slowed sharply as it faces fierce competition from Eli Lilly’s Mounjaro jabs and the threat of US tariffs. Continue reading...


today 3 w. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Events
attach_file Events
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 1249343080
Add Watch Country

arrow_drop_down